Importantly, Treg-specific ablation of Il23r led to an equally reduced tumor burden, phenocopying the kinetics observed in Il23rdel/del mice, suggesting that Treg cells are the relevant target of IL-23 (Fig. 2b–d and Extended Data Fig. 2c). The gene discussed is IL37; the disease is neoplasm.